Yale Cancer Center is pleased to announce that Etienne Leveille, MD, has been selected by the Lymphoma Research Foundation to receive a Postdoctoral Fellowship Grant. This award is designed to support investigators in laboratory or clinic- based research related to the treatment, diagnosis, or prevention of Hodgkin and/or non-Hodgkin lymphoma, including chronic lymphocytic leukemia.
Dr. Leveille is a medical oncology-hematology fellow in the ABIM Physician-Scientist Research Pathway. His project titled “Leveraging B-cell Metabolic Addictions to Induce Ferroptosis in Diffuse Large B-cell Lymphoma” plans to use engineered diffuse large B-cell lymphoma (DLBCL) cell lines and mouse models to further investigate how ferroptosis (a type of cell death) works in patients with DLBCL for the potential treatment of therapy-resistant cancers. He is also a member of the Center of Molecular and Cellular Oncology and studies ferroptosis and other novel therapeutic approaches in B-cell malignancies under the mentorship of Dr. Markus Müschen.
The Lymphoma Research Foundation remains dedicated to finding a cure for lymphoma through an innovative research program and by supporting the next generation of lymphoma researchers.